Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

MYSTERIOUS: Ayala pharmaceuticals s return on capital employed overview | Mind Blowing Facts

Benzinga Pro data, Ayala Pharmaceuticals (NASDAQ:AYLA) reported Q4 sales of $1.15 million. Earnings fell to a loss of $10.05 million, resulting in a 2.58% decrease from last quarter. Ayala Pharmaceuticals collected $625.00 thousand in revenue during Q3, but reported earnings showed a $9.80 million loss.

Why Is ROCE Significant?

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.